Depomed, Inc.:企業の戦略・SWOT・財務情報

【英語タイトル】Depomed, Inc. - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(DATA904C4476)・商品コード:DATA904C4476
・発行会社(調査会社):MarketLine
・発行日:2018年8月
・ページ数:47
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Depomed, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Depomed, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Depomed, Inc. (Depomed or ‘the company’) is a specialty pharmaceutical company focused on pain and other central nervous system (CNS) conditions. The company primarily operates in the US. Depomed is headquartered in Menlo Park, California.

Scope

- Detailed information on Depomed, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Depomed, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Depomed, Inc. including a breakdown and examination of key business segments
- Intelligence on Depomed, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Depomed, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Depomed, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Depomed, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Depomed, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Depomed, Inc.: Company Overview 9
Depomed, Inc.: Overview and Key Facts 9
Depomed, Inc.: Overview 9
Depomed, Inc.: Key Facts 9
Depomed, Inc.: Key Employees 11
Depomed, Inc.: Key Employee Biographies 12
Depomed, Inc.: Major Products and Services 16
Depomed, Inc.: Company History 17
Depomed, Inc.: Management Statement 21
Depomed, Inc.: Locations and Subsidiaries 23
Depomed, Inc.: Key Competitors 24
Depomed, Inc.: Company Analysis 25
Depomed, Inc.: Business Description 25
Depomed, Inc.: SWOT Analysis 26
Depomed, Inc.: SWOT Overview 26
Depomed, Inc.: Strengths 26
Depomed, Inc.: Weaknesses 27
Depomed, Inc.: Opportunities 27
Depomed, Inc.: Threats 27
Depomed, Inc.: Corporate Financial Deals Activity 29
Depomed, Inc.: Financial Deals Overview 29
Depomed, Inc.: Targets and Partners 31
Depomed, Inc.: Top Deals 2014 – 2018YTD* 32
Depomed, Inc.: Advisors 33
Depomed, Inc.: Top Legal Advisors 33
Depomed, Inc.: Top Financial Advisors 33
Depomed, Inc.: Mergers and Acquisitions 34
Depomed, Inc.: Partnership 35
Depomed, Inc.: Divestments 36
Depomed, Inc.: Private Equity and Ownership 37
Depomed, Inc.: Recent Developments 38
Depomed, Inc.: News and Events Summary 38
Depomed, Inc.: Business Expansion 41
Depomed, Inc.: Corporate Governance 41
Depomed, Inc.: Financial Deals 42
Depomed, Inc.: Financial Performance 43
Depomed, Inc.: Research & Development 44
Appendix 45
Contact Us 45
Methodology 45
About MarketLine 46

List of Tables
Table 1: Depomed, Inc.: Key Facts
Table 2: Depomed, Inc.: Key Employees
Table 3: Depomed, Inc.: Locations and Subsidiaries
Table 4: Depomed, Inc.: Key Competitors
Table 5: Depomed, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Depomed, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Depomed, Inc.: Targets and Partners
Table 8: Depomed, Inc.: Top Deals 2014 - 2018YTD*
Table 9: Depomed, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Depomed, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Depomed, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Depomed, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 13: Depomed, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 14: Depomed, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 15: Depomed, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 16: Depomed, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 17: Depomed, Inc.: News and Events Summary
Table 18: Depomed, Inc.: Business Expansion
Table 19: Depomed, Inc.: Corporate Governance
Table 20: Depomed, Inc.: Financial Deals
Table 21: Depomed, Inc.: Financial Performance
Table 22: Depomed, Inc.: Research & Development

List of Figures
Figure 1: Depomed, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Depomed, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Depomed, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Depomed, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 5: Depomed, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 6: Depomed, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 7: Depomed, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Depomed, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★調査レポート[Depomed, Inc.:企業の戦略・SWOT・財務情報] (コード:DATA904C4476)販売に関する免責事項を必ずご確認ください。
★調査レポート[Depomed, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆